首页> 外文会议>IEEE Nuclear Science Symposium;Medical Imaging Conference >Improved separation of Alzheimer’s disease and related disorders using dual-point amyloid-PET
【24h】

Improved separation of Alzheimer’s disease and related disorders using dual-point amyloid-PET

机译:使用双点淀粉样PET改善阿尔茨海默氏病和相关疾病的分离

获取原文

摘要

18F-Florbetaben (FBB) is an amyloid radiotracer that is being increasingly used to assist the diagnosis of Alzheimers disease (AD). Recent studies have suggested that early acquisitions (immediately after the radiotracer injection) of 18F-FBB data provide information about the neuronal injury. Although this assumption still needs to be corroborated by further studies with larger datasets, this would allow obtaining information about the brain injury and amyloid deposits in single examination, using a dual-point protocol. Despite previous works are focused on analyzing the equivalence between early 18F-FBB-PET and 18F-FDG-PET images, in this work we analyzed whether the information provided by early and standard 18F-FBB-PET acquisitions is complementary and can be used together to improve the automatic separation of AD and non-AD patients. Two approaches were proposed to combine the two images from each patient into a single observation: feature concatenation and multiple kernel learning. Then, a Support Vector Machine classifier was used to separate the groups. The classification performance was estimated using a dataset with 18F-FBB-PET data from 80 patients (44 AD and 36 non-AD) along with a cross-validation scheme. Accuracy, sensitivity and specificity achieved by the proposed approaches were compared to those obtained by approaches using only data from one acquisition. The results suggest that using both 18F-FBB-PET acquisitions improves the automatic separation of AD and non-AD patients. They also corroborate that early 18F-FBB-PET images contains useful information (different to that contained in standard 18F-FBB-PET images) to distinguish between AD and non-AD patients. That would make early 18F-FBB-PET images an affordable way to obtain additional information from amyloid tracers that would result in more accurate diagnosis.
机译: 18 F-FlorbeTaben(FBB)是一种淀粉样蛋白放射反射蛋白,越来越多地用于帮助诊断阿尔茨海默氏病(AD)。最近的研究表明,早期收购(在放射性机构注射后立即) 18 F-FBB数据提供有关神经元损伤的信息。尽管使用较大数据集的进一步研究仍然需要进行这种假设,但是使用双点协议,这将允许在单一检查中获得有关脑损伤和淀粉样膏的信息。尽管以前的作品,专注于分析早期之间的等价 18 F-FBB-PET和 18 F-FDG-PET图像,在这项工作中,我们分析了是否通过早期和标准提供的信息 18 F-FBB-PET采集是互补的,可以一起使用,以改善广告和非AD患者的自动分离。提出了两种方法将每位患者的两个图像组合成单个观察:特征串联和多个内核学习。然后,使用支持向量机分类器分离组。使用数据集估计分类性能 18 来自80名患者(44个AD和36个非广告)的F-FBB-PET数据以及交叉验证方案。将所提出的方法实现的准确性,灵敏度和特异性与通过从一次获取的数据的方法获得的那些进行比较。结果表明使用两者 18 F-FBB-PET获取改善了广告和非AD患者的自动分离。它们还证实了18°F-FBB-PET图像早期包含有用的信息(与标准中包含的不同) 18 F-FBB-PET图像)区分广告和非AD患者。这会提前 18 F-FBB-PET图像是从淀粉样蛋白示踪剂获得其他信息的经济实惠的方法,这将导致更准确的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号